HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix Stiffness: the Conductor of Organ Fibrosis.

AbstractPURPOSE OF REVIEW:
Organ fibrosis is a lethal component of scleroderma. The hallmark of scleroderma fibrosis is extensive extracellular matrix (ECM) deposition by activated myofibroblasts, specialized hyper-contractile cells that promote ECM remodeling and matrix stiffening. The purpose of this review is to discuss novel mechanistic insight into myofibroblast activation in scleroderma.
RECENT FINDINGS:
Matrix stiffness, traditionally viewed as an end point of organ fibrosis, is now recognized as a critical regulator of tissue fibrogenesis that hijacks the normal physiologic wound-healing program to promote organ fibrosis. Here, we discuss how matrix stiffness orchestrates fibrosis by controlling three fundamental pro-fibrotic mechanisms: (a) mechanoactivation of myofibroblasts, (b) integrin-mediated latent transforming growth factor beta 1 (TGF-β1) activation, and (c) activation of non-canonical TGF-β1 signaling pathways. We also summarize novel therapeutic targets for anti-fibrotic therapy based on the mechanobiology of scleroderma. Future research on mechanobiology of scleroderma may lead to important clinical applications such as improved diagnosis and treatment of patients with scleroderma and other fibrotic-related diseases.
AuthorsAlba Santos, David Lagares
JournalCurrent rheumatology reports (Curr Rheumatol Rep) Vol. 20 Issue 1 Pg. 2 (01 19 2018) ISSN: 1534-6307 [Electronic] United States
PMID29349703 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Inflammatory Agents
  • Transforming Growth Factor beta1
Topics
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Extracellular Matrix (drug effects, metabolism, pathology)
  • Fibrosis
  • Humans
  • Myofibroblasts (drug effects, metabolism, pathology)
  • Scleroderma, Systemic (drug therapy, metabolism, pathology, physiopathology)
  • Signal Transduction (drug effects, genetics, physiology)
  • Transforming Growth Factor beta1 (metabolism, physiology)
  • Wound Healing (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: